Article Details

Entasis Therapeutics (ETTX) Receives Outperform Rating from Wedbush

Retrieved on: 2019-04-05 19:03:45

Tags for this article:

Click the tags to see associated articles and topics

Entasis Therapeutics (ETTX) Receives Outperform Rating from Wedbush. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc purchased a new stake in shares of Entasis Therapeutics in the 3rd quarter worth approximately $12,840,000. Hound Partners ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up